全文获取类型
收费全文 | 9291篇 |
免费 | 488篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 115篇 |
儿科学 | 784篇 |
妇产科学 | 399篇 |
基础医学 | 993篇 |
口腔科学 | 168篇 |
临床医学 | 470篇 |
内科学 | 1723篇 |
皮肤病学 | 188篇 |
神经病学 | 347篇 |
特种医学 | 213篇 |
外科学 | 1805篇 |
综合类 | 271篇 |
一般理论 | 3篇 |
预防医学 | 382篇 |
眼科学 | 602篇 |
药学 | 528篇 |
中国医学 | 25篇 |
肿瘤学 | 787篇 |
出版年
2023年 | 75篇 |
2022年 | 173篇 |
2021年 | 325篇 |
2020年 | 159篇 |
2019年 | 230篇 |
2018年 | 317篇 |
2017年 | 204篇 |
2016年 | 274篇 |
2015年 | 246篇 |
2014年 | 369篇 |
2013年 | 403篇 |
2012年 | 609篇 |
2011年 | 616篇 |
2010年 | 395篇 |
2009年 | 291篇 |
2008年 | 479篇 |
2007年 | 506篇 |
2006年 | 472篇 |
2005年 | 387篇 |
2004年 | 295篇 |
2003年 | 303篇 |
2002年 | 257篇 |
2001年 | 221篇 |
2000年 | 218篇 |
1999年 | 195篇 |
1998年 | 87篇 |
1997年 | 59篇 |
1996年 | 49篇 |
1995年 | 42篇 |
1992年 | 94篇 |
1991年 | 95篇 |
1990年 | 71篇 |
1989年 | 69篇 |
1988年 | 71篇 |
1987年 | 74篇 |
1986年 | 80篇 |
1985年 | 104篇 |
1984年 | 56篇 |
1983年 | 56篇 |
1982年 | 39篇 |
1981年 | 35篇 |
1980年 | 34篇 |
1979年 | 80篇 |
1978年 | 45篇 |
1977年 | 47篇 |
1976年 | 39篇 |
1975年 | 35篇 |
1974年 | 42篇 |
1973年 | 48篇 |
1972年 | 46篇 |
排序方式: 共有9803条查询结果,搜索用时 31 毫秒
151.
Megumi Oshima Meg J. Jardine Rajiv Agarwal George Bakris Christopher P. Cannon David M. Charytan Dick de Zeeuw Robert Edwards Tom Greene Adeera Levin Soo Kun Lim Kenneth W. Mahaffey Bruce Neal Carol Pollock Norman Rosenthal David C. Wheeler Hong Zhang Bernard Zinman Hiddo J.L. Heerspink 《Kidney international》2021,99(4):999-1009
- Download : Download high-res image (391KB)
- Download : Download full-size image
152.
153.
J.R. Potts C.M. Maybury A. Salam J.N. Barker K. Agarwal C.H. Smith 《The British journal of dermatology》2017,177(3):637-644
Chronic liver disease is a growing problem worldwide due to obesity, alcohol‐related liver disease and viral hepatitis. Liver fibrosis is generally asymptomatic and patients may not present until they have advanced cirrhosis, when the scope for reversibility is limited. Identification of asymptomatic individuals at an early stage is fundamental to reversing the rising toll of liver‐related morbidity and mortality. Awareness of liver disease and the techniques for diagnosis is important for dermatologists, not only due to the burden of disease in the general population but also because some dermatology cohorts may have an elevated risk. For example, there is an increased prevalence of metabolic syndrome and excess alcohol use in those with psoriasis and hidradenitis suppurativa. In isolation, standard liver function tests lack sensitivity to detect advanced fibrosis and cirrhosis and are of limited value. Traditionally diagnosis has relied on liver biopsy, which remains the gold standard but is both costly and invasive. There have been several recent advances in the development of noninvasive alternatives. These include scoring systems combining clinical and conventional laboratory parameters for use as screening tools, direct serum biomarkers of fibrogenesis and tissue elastography using both ultrasound (Fibroscan) and magnetic resonance. This review summarizes current and future noninvasive diagnostic techniques for evaluation of liver fibrosis. 相似文献
154.
Nidhi Tandon Surbhi Sidana S. Vincent Rajkumar Angela Dispenzieri Morie A. Gertz Martha Q. Lacy 《Amyloid》2017,24(3):183-188
We analysed factors predicting early treatment failure (ETF), after first-line therapy for light-chain amyloidosis (AL). AL amyloidosis patients seen at Mayo Clinic within 90?days of diagnosis, from 2006 to 2015, excluding those who died within 3 months of initial therapy, were analysed retrospectively. ETF was defined as progression requiring treatment change or death within 12 (ETF12) or 24 (ETF24) months of first-line treatment. Non-ETF included those with a follow-up of more than 12 or 24 months who had progression beyond 12 or 24 months. A total of 724 patients met the study criteria; 244 (33.7%) had ETF12 and 388 (53.6%) had ETF24. Patients with ETF12 were older (64.1 vs. 62.2?years) with higher prevalence of cardiac (81 vs. 64.1%) and multi-organ involvement (67.2 vs. 45.4%) and higher proportion of patients with t(11; 14) (58.5 vs. 44.3%) or in higher Mayo 2012 stage (58.5 vs. 41.1%).The median follow-up was 5.4?years from start of initial therapy. In multivariate analysis, presence of t(11; 14) and non-incorporation of autologous transplant in initial therapy are significant predictors of ETF12 (p?=?.01and p?=?.003) and ETF24 (p?=?.0001 and p?=?.005) while Mayo stage is predictive of ETF24 (p?=?.002), but not ETF12. 相似文献
155.
156.
Laura M. Alwan Kenneth Grossmann Daniel Sageser Joan Van Atta Neeraj Agarwal Jeffrey A. Gilreath 《Targeted oncology》2014,9(1):63-71
We compared acute toxicity, drug exposure, in-hospital mortality, and inpatient length of stay between two currently recommended dosing protocols (from the National Comprehensive Cancer Network Guidelines) of high-dose interleukin-2 (IL-2) treatment for patients with metastatic melanoma. Patients with metastatic melanoma who received high-dose IL-2 treatment between 2003 and 2010 were identified. Chemotherapy orders, electronic medical records, paper medical charts, and patient discharge summaries were reviewed retrospectively. We identified 13 patients who had received 600,000 units/kilogram (kg)/dose and 15 patients who had received 720,000 units/kg/dose. Patients in the 720,000 units/kg/dose group had a higher rate of grade 3 and 4 bilirubin elevations (34 vs. 12 %), weight gain (any grade, 96 vs. 89 %), and thrombocytopenia (any grade, 75 vs. 65 %). Patients receiving the higher dose also experienced more dose-limiting neurotoxicity (45 vs. 23 %), large-volume diarrhea (15 vs. 0 %), and hepatotoxicity (7 vs. 0 %). There was no in-hospital mortality during treatment in either group. The average length of stay was similar between both groups (5 days, SD?=?1 for both groups), and the median cumulative IL-2 exposure was similar between both groups for the first course (10.1 vs.10.5 million units/kg) and for all courses (approximately 11–12 million units/kg). Both high-dose IL-2 protocols had comparable in-hospital mortality and cumulative IL-2 exposure. The 720,000 units/kg/dose dosing scheme did not shorten the length of stay but did lead to greater acute toxicity. Therefore, as a result, we recommend 600,000 units/kg/dose when deciding between the two regimens. 相似文献
157.
Autologous serum therapy is a promising therapy for treatment resistant urticaria. This is useful in developing countries as this is economical option. Minimum instruments like centrifuge, syringe and needles are required for the procedure. 相似文献
158.
159.
Sanjib Kumar Ghosh Shashi Raheja Anita Tuli Chitra Raghunandan Sneh Agarwal 《Journal of the American Society of Hypertension》2013,7(2):137-148
The purpose of this study was to analyze whether maternal serum placental growth factor (PlGF) could predict early onset preeclampsia (<32 weeks of gestation) in overweight/obese pregnant women, and whether it could do it more effectively than in normal/underweight pregnant women. A prospective cohort study was conducted on 1678 pregnant women with singleton pregnancies, who were grouped as underweight, normal, overweight, and obese on the basis of body mass index, followed by serum PlGF estimation at 20 to 22 weeks of gestation. A cut-off value of <144 pg/mL for PlGF was determined by Receiver Operating Characteristic curve analysis to identify risk of early onset preeclampsia. Univariate logistic regression analysis revealed significantly stronger association between PlGF <144 pg/mL and early onset preeclampsia in overweight/obese pregnant women (odds ratio 7.64; 95% confidence interval 5.34–10.12; P = .000) than in normal/underweight pregnant women (odds ratio 2.95; 95% confidence interval 1.74–4.26; P = .007). Weight and PlGF levels in study women had a significant negative correlation (r = 0.663; P = .002). Serum PlGF in early second trimester could be an effective predictor of early onset preeclampsia in overweight/obese pregnant women and may be more effective than in normal/underweight pregnant women. 相似文献
160.